查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945500

2026年全球萊姆病檢測市場報告

Lyme Disease Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，萊姆病檢測市場顯著擴張，預計將從2025年的106.8億美元成長到2026年的116.7億美元，複合年成長率達9.3%。過去幾年的成長可歸因於萊姆病發病率的上升、早期診斷意識不足、對傳統血清學檢測的依賴、醫院診斷的增加以及蜱傳疾病監測技術的進步。

預計未來幾年萊姆病檢測市場規模將強勁成長，到2030年將達到164.6億美元，複合年成長率（CAGR）為9.0%。預測期內的成長要素包括人工智慧輔助診斷技術的應用、家用檢測套組的廣泛普及、多病種檢測組合的擴展、政府對蜱傳疾病監測投入的增加以及基於雲端的檢測數據管理的整合。預測期內的主要趨勢包括就地檢驗的擴展、萊姆病居家診斷、多病原體蜱傳疾病檢測組合、快速檢測套組的應用以及個性化診斷通訊協定的製定。

未來幾年，由於蜱傳疾病發生率的上升，萊姆病檢測市場預計將會擴大。蜱傳疾病是指透過受感染的蜱蟲叮咬傳播給人類的一組疾病。蜱蟲是一種小型吸血寄生蟲，棲息於草原、森林和鄉村地區。氣候變遷正在推動蜱蟲棲息地的擴張，增加感染的風險和盛行率，因此也增加了對蜱傳疾病治療的需求。蜱傳疾病是萊姆病的主要傳播途徑，這推動了對萊姆病檢測的需求。早期發現和診斷對於有效控制不斷增加的感染病例至關重要。例如，美國疾病管制與預防中心（CDC）於2025年3月發布的數據顯示，2023年報告的萊姆病病例數超過89,000例，顯示與往年相比，蜱傳疾病的負擔持續居高不下。因此，蜱傳疾病的流行正在推動萊姆病檢測市場的擴張。

萊姆病檢測市場的公司正致力於診斷工具的技術創新，旨在提高檢測準確性、縮短結果交付時間並支持疾病的早期發現。這些診斷工具包括各種設備、試劑盒和技術，它們透過檢測與致病菌伯氏疏螺旋體相關的抗體、抗原或遺傳物質來識別萊姆病的存在。例如，2024年8月，英國生技公司EpitogenX宣布推出一款新的萊姆病診斷試劑盒。這款基於酵素連結免疫吸附試驗（ELISA）的檢測方法採用了該公司專有的「Epitogen」平台技術，包含約120種不同的伯氏疏螺旋體表位，具有高特異性和高靈敏度。該試劑盒僅供研究使用（RUO），能夠實現早期、菌株特異性檢測，並適用於各種實驗室環境，有望提高診斷準確性，並為萊姆病的研究提供更深入的見解。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球萊姆病檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 擴大即時檢測範圍
    • 在家診斷萊姆病
    • 多病原體蜱性行為感染疾病檢測組合
    • 快速檢測套組的引入
    • 個性化診斷通訊協定

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 居家醫療環境
  • 研究所
  • 公共衛生機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球萊姆病檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球萊姆病檢測市場規模、對比及成長率分析
  • 全球萊姆病檢測市場表現：規模與成長，2020-2025年
  • 全球萊姆病檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按測試類型
  • 血清學檢測、核酸檢測、尿液抗原檢測和其他類型的檢測
  • 採用檢查調查方法進行調查的方法
  • 酵素免疫分析法（ELISA）、西方墨點法、聚合酵素鏈鎖反應（PCR）、螢光（IFA）和其他新興技術
  • 按疾病階段
  • 早期檢測萊姆病、擴散性萊姆病、慢性萊姆病和無症狀萊姆病
  • 依檢體類型
  • 血液、尿液、腦脊髓液 (CSF) 和其他血液樣本
  • 最終用戶
  • 醫院/診所、診斷檢查室、居家醫療機構、研究實驗室、公共衛生機構
  • 按類型細分：血清學檢測
  • 酵素免疫分析法、西方墨點法、螢光試驗（IFA）、線性免疫檢測（LIA）
  • 按類型細分：核酸檢測
  • 聚合酵素鏈鎖反應（PCR）、恒溫環型核酸擴增擴增（LAMP）、次世代定序（NGS）
  • 依類型細分：尿抗原檢測
  • 橫向流動化驗、酵素免疫分析法(EIA) 和免疫印跡尿液檢查
  • 按類型細分：其他檢查類型
  • 基於培養的檢測、蜱傳共感染疾病檢測以及人工智慧輔助診斷工具

第10章 區域與國家分析

  • 全球萊姆病檢測市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球萊姆病檢測市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 萊姆病檢測市場：競爭格局及市場佔有率（2024年）
  • 萊姆病檢測市場：公司估值矩陣
  • 萊姆病檢測市場：公司概況
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Labcorp Holdings Inc.
    • Quest Diagnostics Incorporated
    • Eurofins Scientific

第37章：其他領先和創新企業

  • BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年萊姆病檢測市場：提供新機會的國家
  • 2030年萊姆病檢測市場：新興細分市場機會
  • 萊姆病檢測市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MLDTI04_G26Q1

Lyme disease testing involves diagnostic methods used to identify infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, which is commonly transmitted via tick bites. The primary goal of Lyme disease testing is to ensure accurate diagnosis, particularly in individuals presenting symptoms such as fever, fatigue, and the distinctive bull's-eye rash.

The primary types of tests used in Lyme disease diagnostics include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests detect the presence of antibodies or antigens in a patient's blood to determine exposure to infections or immune responses. Common testing techniques include enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Testing is applicable across different disease stages, including early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic infection detection. Various sample types used include blood, urine, cerebrospinal fluid (CSF), and more. These diagnostic procedures are carried out by a range of end users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health agencies.

Tariffs are impacting the Lyme disease testing market by increasing the cost of imported diagnostic reagents, laboratory equipment, and test kits, especially impacting nucleic acid tests and advanced serological assays. Regions such as North America and Europe, which rely on imported high-end testing equipment, face higher production costs and slower adoption rates. Hospitals, diagnostic laboratories, and research institutions are the most affected segments. On the positive side, tariffs are encouraging local manufacturing and development of cost-effective alternatives, which may reduce dependency on imports over time.

The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides lyme disease testing market statistics, including lyme disease testing industry global market size, regional shares, competitors with a lyme disease testing market share, detailed lyme disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. This lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyme disease testing market size has grown strongly in recent years. It will grow from $10.68 billion in 2025 to $11.67 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising incidence of lyme disease, limited awareness about early diagnosis, reliance on conventional serological testing, increasing hospital-based diagnostics, growing research in tick-borne diseases.

The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $16.46 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to adoption of ai-assisted diagnostics, growth in home-testing kits, expansion of multi-disease panels, increasing government funding for tick-borne disease surveillance, integration of cloud-based laboratory data management. Major trends in the forecast period include point-of-care testing expansion, home-based lyme disease diagnostics, multi-pathogen tick-borne panels, rapid test kits adoption, personalized diagnostic protocols.

The increasing incidence of tick-borne diseases is anticipated to drive the expansion of the Lyme disease testing market in the coming years. Tick-borne diseases are a group of illnesses transmitted to humans through the bite of infected ticks, which are small, blood-feeding parasites commonly found in grassy, wooded, or rural regions. The growing need for treatments for tick-borne illnesses is driven by the widening geographic distribution of ticks due to climate change, resulting in greater exposure and higher infection rates. Tick-borne diseases fuel the demand for Lyme disease testing because they represent the primary route of Lyme disease transmission, making early detection and diagnosis essential for managing the increasing number of infection cases effectively. For example, in March 2025, the U.S. Centers for Disease Control and Prevention (CDC), a federal public health agency, reported that over 89,000 Lyme disease cases were recorded in 2023, indicating a persistently high burden of tick-borne illnesses compared to prior years. Thus, the growing prevalence of tick-borne diseases is contributing to the expansion of the Lyme disease testing market.

Companies in the Lyme disease testing market are emphasizing technological innovations in diagnostic tools to improve test accuracy, decrease turnaround times, and support early-stage disease detection. These diagnostic tools include devices, kits, and technologies designed to identify the presence of Lyme disease by detecting antibodies, antigens, or genetic material associated with Borrelia burgdorferi, the bacteria responsible for the disease. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, launched a new Lyme Disease Diagnostic Kit. This ELISA-based assay was developed using the company's proprietary EpitoGen platform and includes approximately 120 distinct Borrelia epitopes, offering high specificity and sensitivity. Designed for research use only (RUO), the kit enables early, strain-specific detection and can be adapted for various laboratory settings, providing enhanced diagnostic accuracy and deeper insights into Lyme disease.

In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics company, formed a partnership with ECO Laboratory to improve early Lyme disease detection. This collaboration focuses on advancing the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test aimed at providing accurate and early detection of Lyme disease. The partnership utilizes ECO Laboratory's CLIA-certified facilities to broaden access to advanced tick-borne disease testing throughout the United States. ECO Laboratory is a US-based diagnostic service provider specializing in Lyme and other tick-borne illnesses.

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Hologic Inc., Seegene Inc.

North America was the largest region in the lyme disease testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lyme disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lyme disease testing market includes revenues earned by entities by providing services such as diagnostic test kit development, laboratory testing services, polymerase chain reaction (PCR)-based testing, serological testing, and point-of-care testing solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyme Disease Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lyme disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyme disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Serological Tests; Nucleic Acid Tests; Urine Antigen Tests; Other Test Types
  • 2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA); Weste Blot; Polymerase Chain Reaction (PCR); Immunofluorescence Assay (IFA); Other Emerging Technologies
  • 3) By Disease Stage: Early Lyme Disease; Disseminated Lyme Disease; Chronic Lyme Disease; Asymptomatic Lyme Disease Detection
  • 4) By Sample Type: Blood; Urine; Cerebrospinal Fluid(CSF); Other Blood Samples
  • 5) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Research Institutions; Public Health Organizations
  • Subsegments:
  • 1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
  • 2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
  • 3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
  • 4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific; BIOMERIEUX; Quidel Corporation; Bio Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A; Meridian Bioscience; Trinity Biotech; T2 Biosystems; IGeneX; Viramed Biotech AG; Ceres Nanosciences; Galaxy Diagnostics; Lyme Diagnostics Ltd; Abbott Laboratories; Siemens Healthineers AG; Hologic Inc.; Seegene Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lyme Disease Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lyme Disease Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lyme Disease Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lyme Disease Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Point-Of-Care Testing Expansion
    • 4.2.2 Home-Based Lyme Disease Diagnostics
    • 4.2.3 Multi-Pathogen Tick-Borne Panels
    • 4.2.4 Rapid Test Kits Adoption
    • 4.2.5 Personalized Diagnostic Protocols

5. Lyme Disease Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Home Care Settings
  • 5.4 Research Institutions
  • 5.5 Public Health Organizations

6. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lyme Disease Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lyme Disease Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lyme Disease Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lyme Disease Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lyme Disease Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lyme Disease Testing Market Segmentation

  • 9.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
  • 9.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
  • 9.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
  • 9.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Cerebrospinal Fluid (CSF), Other Blood Samples
  • 9.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations
  • 9.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
  • 9.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
  • 9.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
  • 9.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

10. Lyme Disease Testing Market Regional And Country Analysis

  • 10.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lyme Disease Testing Market

  • 11.1. Asia-Pacific Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lyme Disease Testing Market

  • 12.1. China Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lyme Disease Testing Market

  • 13.1. India Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lyme Disease Testing Market

  • 14.1. Japan Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lyme Disease Testing Market

  • 15.1. Australia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lyme Disease Testing Market

  • 16.1. Indonesia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lyme Disease Testing Market

  • 17.1. South Korea Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lyme Disease Testing Market

  • 18.1. Taiwan Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lyme Disease Testing Market

  • 19.1. South East Asia Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lyme Disease Testing Market

  • 20.1. Western Europe Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lyme Disease Testing Market

  • 21.1. UK Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lyme Disease Testing Market

  • 22.1. Germany Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lyme Disease Testing Market

  • 23.1. France Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lyme Disease Testing Market

  • 24.1. Italy Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lyme Disease Testing Market

  • 25.1. Spain Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lyme Disease Testing Market

  • 26.1. Eastern Europe Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lyme Disease Testing Market

  • 27.1. Russia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lyme Disease Testing Market

  • 28.1. North America Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lyme Disease Testing Market

  • 29.1. USA Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lyme Disease Testing Market

  • 30.1. Canada Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lyme Disease Testing Market

  • 31.1. South America Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lyme Disease Testing Market

  • 32.1. Brazil Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lyme Disease Testing Market

  • 33.1. Middle East Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lyme Disease Testing Market

  • 34.1. Africa Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lyme Disease Testing Market Regulatory and Investment Landscape

36. Lyme Disease Testing Market Competitive Landscape And Company Profiles

  • 36.1. Lyme Disease Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lyme Disease Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lyme Disease Testing Market Company Profiles
    • 36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

37. Lyme Disease Testing Market Other Major And Innovative Companies

  • BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG

38. Global Lyme Disease Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lyme Disease Testing Market

40. Lyme Disease Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Lyme Disease Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lyme Disease Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lyme Disease Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer